coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Neston & Willaston PCN, Cheshire West and Chester (LAD) · Health Inequalities Profile

    PCN U14878 · NHS Cheshire and Merseyside Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    20,927

    Registered population

    53.3% aged 18–64

    31.3%

    Aged 65+

    ICB 19.0% · England 17.9%

    2.9%

    Ethnic minority (non-White)

    1.0% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    3,882

    Hypertension register

    +6.59% in 3 yrs · England +5.60%

    168

    SMI register

    4.5% of Cheshire West and Chester (LAD)'s

    331

    COPD register

    Reviews +43.30% in 3 yrs

    Forecast to 2030

    4,529

    Hypertension patients, 2030

    +647 on today

    73.3%

    QRISK ≥20% on statins, 2030

    +4.91pp over 3 yrs

    8.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    63.7%
    Under-80 blood pressure control trails despite high recording.

    Under-80 blood pressure control is 63.7% (England 67.8%), down 1.6 pp over 2023 to 2025 (England +2.1 pp), despite 90.2% having a recent reading.

    57.0%
    Asthma review coverage leaves about 660 patients unreviewed.

    Annual asthma reviews reach 57.0% (England 65.7%), leaving about 660 of 1,525 register patients unreviewed alongside 2,811 items per 1,000 aged 5-19 (England 1,488).

    65.6%
    Non-frail diabetes glycaemic control exceeds all comparators.

    Non-frail diabetes HbA1c control at or below 58 mmol/mol reaches 65.6% against 57.5% in the borough, 56.2% in the ICB and 57.4% in England.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 31.3% of the list, consistent with high age-related demand

    Neston & Willaston PCN serves 20,927 registered patients across three practices. On the registered list, patients aged 65+ make up 31.3% (6,549 patients), well above Cheshire West and Chester (LAD) at 20.3%, NHS Cheshire and Merseyside Integrated Care Board at 19.0%, and England at 17.9%. Children aged 0-17 represent 15.4% (LAD 18.5%, ICB 19.2%, England 19.6%). Based on Census usual residents rather than GP registrations, 97.1% identify as White (LAD 95.3%, ICB 93.0%, England 81.1%), with an ethnic minority share of 2.9%. Recorded learning disability prevalence is 0.5% (101 patients; England 0.6%).

    Age profile

    0–1715.4%
    18–6453.3%
    65+31.3%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White97.1%
    Mixed1.3%
    Asian1.0%
    Other0.3%
    Black0.3%

    Older people · falls rows are Cheshire West and Chester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire West and Chester LA)2,1092,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)65.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire West and Chester LA)8931,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire West and Chester LA)14.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.6 with 0.0% Core20 patients across all three practices

    The PCN average IMD decile is 7.6, indicating lower deprivation than Cheshire West and Chester (6.3), the ICB (5.2), and England (5.5). Registered Core20 share is 0.0% (0 estimated patients), below the borough (15.7%), the ICB (31.9%), and England (21.0%). Practice concentration reconciles with the PCN rate: Neston Surgery (decile 7.3), The Willaston Surgery (7.4), and Neston Medical Centre (7.5) each record 0.0% Core20. Area-based deprivation metrics cannot identify need in this catchment, so inequality efforts must focus on clinical inclusion groups.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Neston0.0% · 0 patients
    Neston0.0% · 0 patients
    Willaston0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    168

    SMI register

    0.80% recorded prevalence

    101

    Learning disability register

    0.48% recorded prevalence

    10

    Care homes, 329 beds

    In the PCN catchment

    9.6%

    Provide unpaid care

    Cheshire West and Chester (LAD), Census 2021

    Recorded severe mental illness prevalence is 0.8% (168 patients; LAD 1.0%, ICB 1.1%, England 1.0%), alongside 10 care homes with 329 catchment beds. Inclusion-health registers trail England, so proactive annual health checks and care-home coordination are key service priorities to protect.

    Severe mental illness: physical health checks

    BMI recording on the SMI register is 69.7% (England 82.1%), falling 6.7 pp over 2023 to 2025 (England +5.1 pp), including 67.2% at Neston Surgery and 51.9% at The Willaston Surgery. Alcohol recording is 64.8% (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    3,882

    Hypertension register

    +6.59%

    Register growth, 3 yrs

    Cheshire West and Chester (LAD) +6.60% · England +5.60%

    −1.58pp

    BP control, under 80

    ≤140/90 · −2.59pp aged 80+

    +647

    More patients by 2030

    Forecast 4,529 (20.92%)

    Hypertension case-finding and control

    Hypertension prevalence is 18.4% (Cheshire West and Chester 17.0%, ICB 16.8%, England 15.2%), with recent blood pressure checks reaching 90.2% (England 90.0%). Blood pressure control in under-80s is 63.7%, trailing Cheshire West and Chester (66.3%), the ICB (66.4%) and England (67.8%), and fell 1.6 pp over 2023 to 2025 while England rose +2.1 pp. Overall treatment to target is 68.8% (England 70.3%). Control in under-80s diverges widely: Neston Medical Centre achieved 84.3%, while Neston Surgery reached 55.0% and The Willaston Surgery recorded 46.0%. Fewer hypertensive patients achieve clinical blood pressure control than national benchmarks indicate, so prioritising medication titration and adherence reviews across under-performing practices is warranted.

    Lipids and statins

    QRISK ≥ 20% lipid therapy reached 62.1% (England 63.6%), rising +4.9 pp over 2023 to 2025 (England +3.8 pp), and CKD lipid therapy is 69.8% (England 70.3%). Proactive cardiovascular risk review could improve lipid therapy uptake in high-risk groups.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202656,849£1.80£1.71£1.86£102,328
    Cardiovascular (all), 202571,838£5.60£4.37£3.33£402,293

    In 2026, the PCN prescribed 56,849 lipid-regulating items at £1.80 per item (England £1.86, ICB £1.71). Across these 56,849 items, spend was £3,411 less than at England's unit cost, but £5,116 more than at ICB unit cost. Formulary review may identify opportunities to align spend with ICB benchmarks.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +19.46%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.08%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews reached 57.0% after rising +9.3 pp over 2023 to 2025 (England +2.8 pp), trailing England (65.7%) and leaving about 660 of 1,525 asthma patients without a recorded review. Asthma management prescribing is 2,811 items per 1,000 aged 5-19 (England 1,488). Recorded COPD prevalence is 1.6% (331 patients), below the borough (2.1%) and England (1.9%), presenting a benchmark gap range of +65 to +118 patients, while COPD reviews reach 71.0% (England 76.4%).

    Cancer register and children's immunisation

    The cancer register records 1,302 patients (6.2%, England 3.8%). For Q1 2025/26 childhood immunisations, age-5 MMR dose 1 coverage reached 100.0% (England 91.7%), but dose 2 dropped 10.3 pp to 89.7% (England 82.8%), falling 5.3 pp below the 95.0% target across 39 children. The second-dose gap was 14.3 pp at Neston Medical Centre and 8.3 pp at Neston Surgery.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.4%

    England 91.0%

    6-in-1 complete primary course at 24 months94.1%

    England 92.2%

    MMR dose 1 at 24 months94.1%

    England 88.3%

    MMR dose 2 at age 589.7%

    England 82.8%

    4-in-1 pre-school booster at age 589.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Neston & Willaston PCN records cancer prevalence of 6.2% (1,302 patients), with three-year growth of +14.2% (England +9.0%). PCN cervical screening is 74.2% (England 66.8%) and breast screening 75.9% (England 69.9%), though cervical coverage at The Willaston Surgery is 64.5%. In the wider system, 55.5% of ICB cancers with a known stage were diagnosed at stage 1 or 2 in 2022 (7,482 of 13,490; 72.8% staged), matching England (55.3%) but below the 75.0% ambition by 19.5 pp—a system gap of about 2,640 early cases. Tackling cervical screening variation between practices could help sustain early identification across the PCN.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    As wider-system provider context, in July 2026, Wirral University Teaching Hospital NHS Foundation Trust achieved 77.6% on the cancer 62-day referral to treatment standard, below the 85.0% standard by 7.4 pp, but ahead of Liverpool University Hospitals NHS Foundation Trust (73.3%), NHS Cheshire and Merseyside ICB (76.2%), and England (71.2%), while trailing Countess of Chester Hospital NHS Foundation Trust (83.3%). On the 28-day faster diagnosis standard, the trust reached 74.7% (England 79.3%). Across all diagnostic tests, 5.0% waited 6+ weeks (England 23.1%), though colonoscopy waits reached 32.8% (England 30.8%).

    Pathways within standard (%)WirralCountess of ChesterLiverpoolCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)74.7187.3775.4777.2579.32
    31-day treatment (96%)92.5393.4890.5195.7192.50
    62-day referral to treatment (85%)77.6583.2873.2676.2371.16
    Diagnostic waits over 6 weeks (%)WirralCountess of ChesterLiverpoolEngland
    MRI1.5411.266.4221.40
    CT1.554.180.719.92
    Echocardiography5.0731.4412.5528.48
    Colonoscopy32.8126.4433.1430.83
    Gastroscopy17.7327.5244.9929.02
    All 15 DM01 tests5.0220.1611.5023.14
    Community services activityCheshire West and Chester residentsCheshire and Merseyside ICB
    Care contacts47,655541,280
    Referrals10,32597,150
    Patients with a contact18,585146,240

    Community services (residents of Cheshire West and Chester), Jun 2026 (provisional). In June 2026, provisional community services data recorded 47,655 care contacts and 122,185 activities for Cheshire West and Chester residents, alongside 541,280 contacts and 1,332,205 activities across NHS Cheshire and Merseyside ICB. Adults aged 65+ accounted for 52.7% of borough contacts (25,095 contacts). These experimental figures reflect substantial older-age community demand, though activity was not captured for PCN registered patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 19.8 pp and vaccination achievement diverges by 36.9 pp

    Across England, overall 2025/26 QOF achievement is 92.5%. Neston Surgery achieves 97.2% and Neston Medical Centre reaches 96.9%, while The Willaston Surgery records 91.7%. Vaccination achievement spans 36.9 pp, from 98.4% at Neston Surgery to 61.5% at The Willaston Surgery. The Willaston Surgery also records a 13.4% personalised care adjustment rate (England 10.0%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Neston Surgery1220.055.8%83.9%92.8%
    Neston1300.075.6%78.7%89.5%
    Willaston1240.059.4%74.6%77.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire West and Chester (LAD)AssetPCNCheshire West and Chester (LAD)
    Care homes (catchment)10 (329 beds)n/aSchools (catchment)20n/a
    Children's centres115Places of worship18231
    Libraries216Food banks (VCS)n/a1
    Homelessness support (VCS)n/a1Day centres (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)670
    Primary academies146Special schoolsn/a5

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension titration and CVD prescribing review

    Under-80 BP control is 63.7% (England 67.8%; fell 1.6 pp vs England +2.1 pp), QRISK ≥ 20% lipid therapy is 62.1% (England 63.6%), and CVD spend is £163,072 more than England's unit cost across 71,838 items. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured asthma review and prescribing recall

    Annual asthma review coverage is 57.0% vs 65.7% in England (8.7 pp below), leaving 656 (about 660) of 1,525 patients unreviewed, alongside 2,811 items per 1,000 aged 5-19 (England 1,488). For discussion: align annual asthma recall with repeat inhaler prescribing reviews, offering after-school slots for children and young people. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    COPD case-finding and annual review audit

    Recorded COPD prevalence is 1.6% (331 patients) vs 1.9% in England and 2.1% in the borough, a benchmark gap of +65 to +118 patients, with annual reviews at 71.0% (England 76.4%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register audit (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Inclusion health targeting review (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall audit (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension medication titration review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall tracking (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Telephony and triage access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension titration and CVD prescribing review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Structured asthma review and prescribing recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · COPD case-finding and annual review audit (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15